Papillary Renal Cell Cancer Explained: Symptoms, Treatment & More
Papillary renal cell cancer, often abbreviated as pRCC, is a type of kidney cancer that originates from the renal cells lining the tiny tubes (tubules) within the kidneys. Understanding this condition is crucial for anyone who suspects they may have it, or for anyone supporting someone going through diagnosis, treatment, or recovery. Let's delve into the details of this condition, its causes, symptoms, diagnosis, and treatment options.
Renal cell cancer, also known as renal adenocarcinoma, is a group of cancers that starts in the kidneys. Among these, papillary renal cell cancer is the second most common type, comprising around 10-15% of all renal cell cancers. It was once thought to be more aggressive than other types, but now it's clear that most pRCCs have a better prognosis compared to clear cell renal cell carcinoma, the most common type.
Understanding Papillary Renal Cell Cancer
Papillary renal cell cancer gets its name from the finger-like projections (papillae) it forms under the microscope. These papillae are composed of two layers of tumor cells. Unlike other kidney cancers, pRCC often has a distinct pattern of genetic alterations that can help in diagnosis and understanding its behavior.
pRCC can be further subclassified into types 1 and 2, based on the appearance of the tumor cells under the microscope. Type 1 pRCC has seabuding pale cells with round nuclei, while Type 2 pRCC has eosinophilic cells with irregular nuclei. Understanding these subtypes can help guide treatment decisions.
Causes and Risk Factors
The exact cause of papillary renal cell cancer is not clear. However, like many cancers, it's thought to be related to DNA changes (mutations) that occur over time. Several genetic alterations have been identified in pRCC, with some occurring more frequently in type 1 or type 2 tumors.
Certain risk factors can increase the likelihood of developing pRCC, including family history of kidney cancer, obesity, smoking, and long-term use of certain medications. However, having these risk factors doesn't mean you'll definitely get pRCC, and many people with these factors never develop the condition.
Symptoms and Detection
In the early stages, pRCC often doesn't cause any symptoms. As the tumor grows, it may lead to a lump or pain in the flank (the side between your ribs and hips). Other symptoms might include blood in the urine, fatigue, and weight loss. These symptoms are non-specific and can be caused by many other conditions, so it's important to consult a healthcare provider for proper evaluation.
Most pRCCs are detected incidentally during imaging tests for other health issues. When symptoms do occur, they're often evaluated with a thorough physical exam, blood and urine tests, and imaging studies such as X-rays, CT scans, or MRIs. A biopsy may also be done to confirm the diagnosis and determine the specific subtype of pRCC.
Management and Treatment Options
The treatment plan for papillary renal cell cancer depends on several factors, including the size, stage, and subtype of the tumor, as well as the patient's overall health. The main treatment options are surgery, targeted therapies, and supportive care.
Surgery is the primary treatment for localized pRCC. The goal is to remove the tumor completely while preserving as much kidney function as possible. This might involve a partial nephrectomy (removing just the tumor and some surrounding tissue) or a radical nephrectomy (removing the entire kidney).
Neoadjuvant and Adjuvant Treatments
Neoadjuvant treatment is given before surgery to shrink the tumor and make it easier to remove. Adjuvant treatment is given after surgery to reduce the risk of the cancer coming back. These treatments might include targeted therapies, which work by blocking the growth and spread of cancer cells, or Immunotherapy, which helps the body's immune system recognize and fight cancer cells.
Clinical trials may be an option for some patients. These studies test new treatments in a controlled setting to see if they're safe and effective. Participating in a clinical trial can provide access to promising new treatments and help advance research.
Learning that you or a loved one has cancer can be scary and overwhelming. However, understanding the condition and exploring treatment options with a healthcare team can empower you to navigate this journey. Regular follow-ups and open communication with healthcare providers are crucial for catching any potential recurrences early and making timely treatment decisions.